▶ 調査レポート

インフルエンザ診断の世界市場

• 英文タイトル:Global Market Study on Influenza Diagnostics: Increasing Availability of Rapid Influenza Diagnostic Tests Aiding Market Growth

Persistence Market Researchが調査・発行した産業分析レポートです。インフルエンザ診断の世界市場 / Global Market Study on Influenza Diagnostics: Increasing Availability of Rapid Influenza Diagnostic Tests Aiding Market Growth / PMR2008043資料のイメージです。• レポートコード:PMR2008043
• 出版社/出版日:Persistence Market Research / 2020年5月28日
• レポート形態:英文、PDF、239ページ
• 納品方法:Eメール
• 産業分類:生命科学
• 販売価格(消費税別)
  Individual User(1名用)¥725,200 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥1,124,800 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,568,800 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、インフルエンザ診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルスの危機分析、テスト種類別(分子診断テスト、従来型診断テスト)分析、インフルエンザ種類別(A型インフルエンザ、B型インフルエンザ、C型インフルエンザ)分析、エンドユーザー別(病院、診断研究所、学術研究機関、受託研究機関(CRO))分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・市場背景
・新型コロナウイルスの危機分析
・インフルエンザ診断の世界市場規模:テスト種類別(分子診断テスト、従来型診断テスト)
・インフルエンザ診断の世界市場規模:インフルエンザ種類別(A型インフルエンザ、B型インフルエンザ、C型インフルエンザ)
・インフルエンザ診断の世界市場規模:エンドユーザー別(病院、診断研究所、学術研究機関、受託研究機関(CRO))
・インフルエンザ診断の世界市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法

Influenza Diagnostics Market – Scope of the Report

The latest publication by Persistence Market Research (PMR) on the global influenza diagnostics market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global influenza diagnostics market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the influenza diagnostics market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for successful growth in the influenza diagnostics market are presented in this comprehensive report, including Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR’s research. This research study can support readers in knowing the demand for influenza diagnostics and quantitative development opportunities during the study period.

The research is beneficial for shareholders in influenza diagnostics, including influenza diagnostics market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the influenza diagnostics market. The insights and wisdom presented in PMR’s study can be leveraged by shareholders in the influenza diagnostics market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to macro- as well as micro-economic variables affecting the business scenario in the influenza diagnostics market are also included in the study. Depending on potential developments in the influenza diagnostics market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the influenza diagnostics industry can make suitable business choices to achieve traction in the influenza diagnostics market.

Key Questions Answered in PMR’s Influenza Diagnostics Market Report

Which regions will continue to remain the most profitable regional markets for influenza diagnostics market players?
Which factors will induce a change in the demand for influenza diagnostics during the assessment period?
How will changing trends impact the influenza diagnostics market?
How can market players capture the low-hanging opportunities in the influenza diagnostics market in developed regions?
What are the winning strategies of stakeholders in the influenza diagnostics market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and tackle while investing in the influenza diagnostics market?
What are the developmental trends in influenza diagnostics sectors that will impact the market?
How can businesses in the influenza diagnostics market avail the growth opportunities in developed and emerging sectors?
Influenza Diagnostics Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the influenza diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the influenza diagnostics market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the influenza diagnostics market, and makes PMR’s projections on the growth prospects of the influenza diagnostics market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product type Innovation / Development Trends

4. Key Success Factors

4.1. Influenza Diagnostics Adoption Rate/Usage Analysis- Key Statistics

4.2. Key Promotional Strategies, By Key Manufacturers

4.3. Key Regulations, By Region

4.4. Disease Epidemiology

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

1.1.1. Global Healthcare Industry Market Outlook

1.1.2. Global Life Science Market Outlook

5.2. Forecast Factors – Relevance & Impact

1.1.3. Key Players Historical Growth

1.1.4. Product Adoption Across Regions

1.1.5. Product cost

1.1.6. Disease Prevalence

1.1.7. In-patient Statistics

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

6.1. Current COVID19 Statistics and Probable Future Impact

6.2. Current GDP Projection and Probable Impact

6.3. Current Economic Projection as compared to 2020 financial analysis

6.4. COVID19 and Impact Analysis

6.4.1. Revenue By Product

6.4.2. Revenue By Country

6.5. 2020 Market Scenario

6.6. Quarter by Quarter Forecast

6.7. Projected recovery Quarter

6.8. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Influenza Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By Test Type

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) By Test Type, 2015-2019

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2020-2030

8.3.1. Molecular Diagnostic Tests

8.3.1.1. RT-PCR

8.3.1.2. LAMP

8.3.1.3. NASBA

8.3.2. Traditional Diagnostic Tests

8.3.2.1. Rapid Influenza Detection Tests

8.3.2.2. Serological Assays

8.3.2.3. Direct Fluorescent Antibody

8.3.2.4. Viral Culture

8.3.2.5. H1N1 Influenza A Virus Identification Kits

8.3.2.6. Immunoassay Kits

8.3.2.7. Immunofluorescence Antibody Assay

8.4. Market Attractiveness Analysis By Test Type

9. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) By Type of Flu , 2015-2019

9.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Type of Flu , 2020-2030

9.3.1. Type A Flu

9.3.2. Type B Flu

9.3.3. Type C Flu

9.4. Market Attractiveness Analysis By Test Type

10. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By End User

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) and By End User, 2015-2019

10.3. Current and Future Market Size (US$ Mn) and Forecast By End User, 2020-2030

10.3.1.1. Hospitals

10.3.1.2. Diagnostic Laboratories

10.3.1.3. Research and Academic Institute

10.3.1.4. Contract research organization (CROs)

10.4. Market Attractiveness Analysis by End User

11. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By Region

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 – 2019

11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 – 2030

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. East Asia

11.3.5. South Asia

11.3.6. Oceania

11.3.7. Middle East and Africa (MEA)

11.4. Market Attractiveness Analysis By Region

12. North America Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. By Test Type

12.3.3. By Type of Flu

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Latin America Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

13.3.1. By Country

13.3.1.1. Brazil

13.3.1.2. Mexico

13.3.1.3. Argentina

13.3.1.4. Rest of Latin America

13.3.2. By Test Type

13.3.3. By Type of Flu

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Europe Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. BENELUX

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. By Test Type

14.3.3. By Type of Flu

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. South Asia Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Thailand

15.3.1.3. Indonesia

15.3.1.4. Malaysia

15.3.1.5. Rest of South Asia

15.3.2. By Test Type

15.3.3. By Type of Flu

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. East Asia Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. By Test Type

16.3.3. By Type of Flu

16.3.4. By End User

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. Oceania Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By Test Type

17.3.3. By Type of Flu

17.3.4. By End User

17.4. Market Attractiveness Analysis

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Middle East and Africa Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. Turkey

18.3.1.3. South Africa

18.3.1.4. Rest of Middle East and Africa

18.3.2. By Test Type

18.3.3. By Type of Flu

18.3.4. By End User

18.4. Market Attractiveness Analysis

18.5. Key Market Participants – Intensity Mapping

18.6. Drivers and Restraints – Impact Analysis

19. Key and Emerging Countries Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.1.1. Market Value Proportion Analysis, By Key Countries

19.1.2. Global Vs. Country Growth Comparison

19.2. U.S. Influenza Diagnostics Market Analysis

19.2.1. By Test Type

19.2.2. By Type of Flu

19.2.3. By End User

19.3. Canada Influenza Diagnostics Market Analysis

19.3.1. By Test Type

19.3.2. By Type of Flu

19.3.3. By End User

19.4. Mexico Influenza Diagnostics Market Analysis

19.4.1. By Test Type

19.4.2. By Type of Flu

19.4.3. By End User

19.5. Brazil Influenza Diagnostics Market Analysis

19.5.1. By Test Type

19.5.2. By Type of Flu

19.5.3. By End User

19.6. U.K. Influenza Diagnostics Market Analysis

19.6.1. By Test Type

19.6.2. By Type of Flu

19.6.3. By End User

19.7. Germany Influenza Diagnostics Market Analysis

19.7.1. By Test Type

19.7.2. By Type of Flu

19.7.3. By End User

19.8. France Influenza Diagnostics Market Analysis

19.8.1. By Test Type

19.8.2. By Type of Flu

19.8.3. By End User

19.9. Italy Influenza Diagnostics Market Analysis

19.9.1. By Test Type

19.9.2. By Type of Flu

19.9.3. By End User

19.10. Spain Influenza Diagnostics Market Analysis

19.10.1. By Test Type

19.10.2. By Type of Flu

19.10.3. By End User

19.11. BENELUX Influenza Diagnostics Market Analysis

19.11.1. By Test Type

19.11.2. By Type of Flu

19.11.3. By End User

19.12. Russia Influenza Diagnostics Market Analysis

19.12.1. By Test Type

19.12.2. By Type of Flu

19.12.3. By Age Group

19.13. China Influenza Diagnostics Market Analysis

19.13.1. By Test Type

19.13.2. By Type of Flu

19.13.3. By End User

19.14. Japan Influenza Diagnostics Market Analysis

19.14.1. By Test Type

19.14.2. By Type of Flu

19.14.3. By End User

19.15. South Korea Influenza Diagnostics Market Analysis

19.15.1. By Test Type

19.15.2. By Type of Flu

19.15.3. By End User

19.16. India Influenza Diagnostics Market Analysis

19.16.1. By Test Type

19.16.2. By Type of Flu

19.16.3. By End User

19.17. Indonesia Influenza Diagnostics Market Analysis

19.17.1. By Test Type

19.17.2. By Type of Flu

19.17.3. By End User

19.18. Australia Influenza Diagnostics Market Analysis

19.18.1. By Test Type

19.18.2. By Type of Flu

19.18.3. By End User

19.19. New Zealand Influenza Diagnostics Market Analysis

19.19.1. By Test Type

19.19.2. By Type of Flu

19.19.3. By End User

19.20. GCC Countries Influenza Diagnostics Market Analysis

19.20.1. By Test Type

19.20.2. By Type of Flu

19.20.3. By End User

19.21. Turkey Influenza Diagnostics Market Analysis

19.21.1. By Test Type

19.21.2. By Type of Flu

19.21.3. By End User

19.22. South Africa Influenza Diagnostics Market Analysis

19.22.1. By Test Type

19.22.2. By Type of Flu

19.22.3. By End User

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies

20.2. Market Share Analysis of Top Players

20.3. Market Presence Analysis

20.3.1.1. Regional footprint of Players

20.3.1.2. Product type foot print by Players

20.3.1.3. Channel Foot Print by Players

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Benchmarking

21.3. Competition Deep Dive

21.3.1. Abbott Laboratories

21.3.1.1. Overview

21.3.1.2. Product type Portfolio

21.3.1.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.1.4. Sales Footprint

21.3.1.5. Analyst Commentary

21.3.1.6. Strategy Overview

21.3.1.6.1. Marketing Strategy

21.3.1.6.2. Product type Strategy

21.3.1.6.3. Channel Strategy

21.3.2. Endress+Hauser (Analytik Jena AG)

21.3.2.1. Overview

21.3.2.2. Product type Portfolio

21.3.2.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.2.4. Sales Footprint

21.3.2.5. Analyst Commentary

21.3.2.6. Strategy Overview

21.3.2.6.1. Marketing Strategy

21.3.2.6.2. Product type Strategy

21.3.2.6.3. Channel Strategy

21.3.3. Becton, Dickinson and Company

21.3.3.1. Overview

21.3.3.2. Product type Portfolio

21.3.3.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.3.4. Sales Footprint

21.3.3.5. Analyst Commentary

21.3.3.6. Strategy Overview

21.3.3.6.1. Marketing Strategy

21.3.3.6.2. Product type Strategy

21.3.3.6.3. Channel Strategy

21.3.4. Biocartis

21.3.4.1. Overview

21.3.4.2. Product type Portfolio

21.3.4.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.4.4. Sales Footprint

21.3.4.5. Analyst Commentary

21.3.4.6. Strategy Overview

21.3.4.6.1. Marketing Strategy

21.3.4.6.2. Product type Strategy

21.3.4.6.3. Channel Strategy

21.3.5. bioMérieux Inc

21.3.5.1. Overview

21.3.5.2. Product type Portfolio

21.3.5.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.5.4. Sales Footprint

21.3.5.5. Analyst Commentary

21.3.5.6. Strategy Overview

21.3.5.6.1. Marketing Strategy

21.3.5.6.2. Product type Strategy

21.3.5.6.3. Channel Strategy

21.3.6. Danaher Corporation (Cepheid)

21.3.6.1. Overview

21.3.6.2. Product type Portfolio

21.3.6.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.6.4. Sales Footprint

21.3.6.5. Analyst Commentary

21.3.6.6. Strategy Overview

21.3.6.6.1. Marketing Strategy

21.3.6.6.2. Product type Strategy

21.3.6.6.3. Channel Strategy

21.3.7. F. Hoffmann-La Roche Ltd

21.3.7.1. Overview

21.3.7.2. Product type Portfolio

21.3.7.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.7.4. Sales Footprint

21.3.7.5. Analyst Commentary

21.3.7.6. Strategy Overview

21.3.7.6.1. Marketing Strategy

21.3.7.6.2. Product type Strategy

21.3.7.6.3. Channel Strategy

21.3.8. GenMark Diagnostics, Inc.

21.3.8.1. Overview

21.3.8.2. Product type Portfolio

21.3.8.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.8.4. Sales Footprint

21.3.8.5. Analyst Commentary

21.3.8.6. Strategy Overview

21.3.8.6.1. Marketing Strategy

21.3.8.6.2. Product type Strategy

21.3.8.6.3. Channel Strategy

21.3.9. Luminex Corporation

21.3.9.1. Overview

21.3.9.2. Product type Portfolio

21.3.9.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.9.4. Sales Footprint

21.3.9.5. Analyst Commentary

21.3.9.6. Strategy Overview

21.3.9.6.1. Marketing Strategy

21.3.9.6.2. Product type Strategy

21.3.9.6.3. Channel Strategy

21.3.10. Meridian Bioscience, Inc

21.3.10.1. Overview

21.3.10.2. Product type Portfolio

21.3.10.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.10.4. Sales Footprint

21.3.10.5. Analyst Commentary

21.3.10.6. Strategy Overview

21.3.10.6.1. Marketing Strategy

21.3.10.6.2. Product type Strategy

21.3.10.6.3. Channel Strategy

21.3.11. Quidel Corporation

21.3.11.1. Overview

21.3.11.2. Product type Portfolio

21.3.11.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.11.4. Sales Footprint

21.3.11.5. Analyst Commentary

21.3.11.6. Strategy Overview

21.3.11.6.1. Marketing Strategy

21.3.11.6.2. Product type Strategy

21.3.11.6.3. Channel Strategy

21.3.12. Thermo Fisher Scientific Inc.

21.3.12.1. Overview

21.3.12.2. Product type Portfolio

21.3.12.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.12.4. Sales Footprint

21.3.12.5. Analyst Commentary

21.3.12.6. Strategy Overview

21.3.12.6.1. Marketing Strategy

21.3.12.6.2. Product type Strategy

21.3.12.6.3. Channel Strategy

21.3.13. Hologic

21.3.13.1. Overview

21.3.13.2. Product type Portfolio

21.3.13.3. Profitability by Market Segments (Product type/Channel/Region)

21.3.13.4. Sales Footprint

21.3.13.5. Analyst Commentary

21.3.13.6. Strategy Overview

21.3.13.6.1. Marketing Strategy

21.3.13.6.2. Product type Strategy

21.3.13.6.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

List of Table

Table 1: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 2: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 3: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 4: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region

Table 5: North America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 6: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 7: North America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 8: North America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 9: Latin America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 10: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 11: Latin America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 12: Latin America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 13: Europe Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 14: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 15: Europe Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 16: Europe Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 17: South Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 18: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 19: South Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 20: South Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 21: East Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 22: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 23: East Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 24: East Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 25: Oceania Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 26: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 27: Oceania Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 28: Oceania Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 29: Middle East and Africa Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 30: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 31: Middle East and Africa Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 32: Middle East and Africa Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country